- •Foreword
- •Preface
- •Contents
- •Chapter 1
- •The Apparently Blind Infant
- •Introduction
- •Hereditary Retinal Disorders
- •Leber Congenital Amaurosis
- •Joubert Syndrome
- •Congenital Stationary Night Blindness
- •Achromatopsia
- •Congenital Optic Nerve Disorders
- •Cortical Visual Insufficiency
- •Causes of Cortical Visual Loss
- •Perinatal Hypoxia-Ischemia
- •Postnatal Hypoxia-Ischemia
- •Cerebral Malformations
- •Head Trauma
- •Twin Pregnancy
- •Metabolic and Neurodegenerative Conditions
- •Meningitis, Encephalitis, and Sepsis
- •Hydrocephalus, Ventricular Shunt Failure
- •Preictal, Ictal, or Postictal Phenomena
- •Associated Neurologic and Systemic Disorders
- •Characteristics of Visual Function
- •Neuro-Ophthalmologic Findings
- •Diagnostic and Prognostic Considerations
- •Role of Visual Attention
- •Neuroimaging Abnormalities and their Implications
- •Subcortical Visual Loss (Periventricular Leukomalacia)
- •Perceptual Difficulties
- •Dorsal and Ventral Stream Dysfunction
- •Pathophysiology
- •Intraventricular Hemorrhage
- •Hemianopic Visual Field Defects in Children
- •Delayed Visual Maturation
- •Blindsight
- •The Effect of Total Blindness on Circadian Regulation
- •Horizons
- •References
- •Chapter 2
- •Congenital Optic Disc Anomalies
- •Introduction
- •Optic Nerve Hypoplasia
- •Segmental Optic Nerve Hypoplasia
- •Excavated Optic Disc Anomalies
- •Morning Glory Disc Anomaly
- •Optic Disc Coloboma
- •Peripapillary Staphyloma
- •Megalopapilla
- •Optic Pit
- •Congenital Tilted Disc Syndrome
- •Optic Disc Dysplasia
- •Congenital Optic Disc Pigmentation
- •Aicardi Syndrome
- •Doubling of the Optic Disc
- •Optic Nerve Aplasia
- •Myelinated (Medullated) Nerve Fibers
- •The Albinotic Optic Disc
- •References
- •Chapter 3
- •The Swollen Optic Disc in Childhood
- •Introduction
- •Papilledema
- •Pathophysiology
- •Neuroimaging
- •Primary IIH in Children
- •Secondary IIH
- •IIH Secondary to Neurological Disease
- •IIH Secondary to Systemic Disease
- •Malnutrition
- •Severe Anemia
- •Addison Disease
- •Bone Marrow Transplantation
- •Renal Transplantation
- •Down Syndrome
- •Gliomatosis Cerebri
- •Systemic Lupus Erythematosis
- •Sleep Apnea
- •Postinfectious
- •Childhood IIH Associated with Exogenous Agents
- •Atypical IIH
- •Treatment of IIH in Children
- •Prognosis of IIH in Children
- •Optic Disc Swelling Secondary to Neurological Disease
- •Hydrocephalus
- •Neurofibromatosis
- •Spinal Cord Tumors
- •Subacute Sclerosing Panencephalitis
- •Optic Disc Swelling Secondary to Systemic Disease
- •Diabetic Papillopathy
- •Malignant Hypertension
- •Sarcoidosis
- •Leukemia
- •Cyanotic Congenital Heart Disease
- •Craniosynostosis Syndromes
- •Nonaccidental Trauma (Shaken Baby Syndrome)
- •Cysticercosis
- •Mucopolysaccharidosis
- •Infantile Malignant Osteopetrosis
- •Malaria
- •Paraneoplastic
- •Uveitis
- •Blau Syndrome
- •CINCA
- •Kawasaki Disease
- •Poststreptococal Uveitis
- •Intrinsic Optic Disc Tumors
- •Optic Disc Hemangioma
- •Tuberous Sclerosis
- •Optic Disc Glioma
- •Combined Hamartoma of the Retina and RPE
- •Retrobulbar Tumors
- •Optic Neuritis in Children
- •History and Physical Examination
- •Postinfectious Optic Neuritis
- •Acute Disseminated Encephalomyelitis
- •MS and Pediatric Optic Neuritis
- •Devic Disease (Neuromyelitis Optica)
- •Prognosis and Treatment
- •Course of Visual Loss and Visual Recovery
- •Systemic Prognosis
- •Systemic Evaluation of Pediatric Optic Neuritis
- •Treatment
- •Leber Idiopathic Stellate Neuroretinitis
- •Ischemic Optic Neuropathy
- •Autoimmune Optic Neuropathy
- •Pseudopapilledema
- •Optic Disc Drusen
- •Epidemiology
- •Ophthalmoscopic Appearance in Children
- •Distinguishing Buried Disc Drusen from Papilledema
- •Fluorescein Angiographic Appearance
- •Neuroimaging
- •Histopathology
- •Pathogenesis
- •Ocular Complications
- •Systemic Associations
- •Natural History and Prognosis
- •Systemic Disorders Associated with Pseudopapilledema
- •Down Syndrome
- •Alagille Syndrome
- •Kenny Syndrome
- •Leber Hereditary Neuroretinopathy
- •Mucopolysaccharidosis
- •Linear Sebaceous Nevus Syndrome
- •Orbital Hypotelorism
- •References
- •Chapter 4
- •Optic Atrophy in Children
- •Introduction
- •Epidemiology
- •Optic Atrophy Associated with Retinal Disease
- •Congenital Optic Atrophy Vs. Hypoplasia
- •Causes of Optic Atrophy in Children
- •Compressive/Infiltrative Intracranial Lesions
- •Optic Glioma
- •Craniopharyngioma
- •Noncompressive Causes of Optic Atrophy in Children with Brain Tumors
- •Postpapilledema Optic Atrophy
- •Paraneoplastic Syndromes
- •Radiation Optic Neuropathy
- •Hydrocephalus
- •Hereditary Optic Atrophy
- •Dominant Optic Atrophy (Kjer Type)
- •Leber Hereditary Optic Neuropathy
- •Recessive Optic Atrophy
- •X-Linked Optic Atrophy
- •Behr Syndrome
- •Wolfram Syndrome (DIDMOAD)
- •Toxic/Nutritional Optic Neuropathy
- •Neurodegenerative Disorders with Optic Atrophy
- •Krabbe’s Infantile Leukodystrophy
- •Canavan Disease (Spongiform Leukodystrophy)
- •PEHO Syndrome
- •Neonatal Leukodystrophy
- •Metachromatic Leukodystrophy
- •Pantothenate Kinase-Associated Neurodegeneration
- •Neuronal Ceroid Lipofuscinoses (Batten Disease)
- •Familial Dysautonomia (Riley–Day Syndrome)
- •Infantile Neuroaxonal Dystrophy
- •Organic Acidurias
- •Propionic Acidemia
- •Cobalamin C Deficiency with Methylmalonic Acidemia
- •Spinocerebellar Degenerations
- •Hereditary Polyneuropathies
- •Mucopolysaccharidoses
- •Optic Atrophy due to Hypoxia-Ischemia
- •Traumatic Optic Atrophy
- •Vigabatrin
- •Carboplatin
- •Summary of the General Approach to the Child with Optic Atrophy
- •References
- •Chapter 5
- •Transient, Unexplained, and Psychogenic Visual Loss in Children
- •Introduction
- •Transient Visual Loss
- •Migraine
- •Migraine Aura
- •Amaurosis Fugax as a Migraine Equivalent
- •Migraine Versus Retinal Vasospasm
- •Migraine Headache
- •Complicated Migraine
- •Pathophysiology
- •Genetics
- •Sequelae
- •Treatment
- •Epilepsy
- •Epileptiform Visual Symptoms with Seizure Aura
- •Ictal Cortical Blindness
- •Postictal Blindness
- •Distinguishing Epilepsy from Migraine
- •Vigabitrin-Associated Visual Field Loss
- •Posttraumatic Transient Cerebral Blindness
- •Cardiogenic Embolism
- •Nonmigrainous Cerebrovascular Disease
- •Transient Visual Obscurations Associated with Papilledema
- •Anomalous Optic Discs
- •Entoptic Images
- •Media Opacities
- •Retinal Circulation
- •Phosphenes
- •Uhthoff Symptom
- •Alice in Wonderland Syndrome
- •Charles Bonnet Syndrome
- •Lilliputian Hallucinations
- •Palinopsia
- •Peduncular Hallucinosis
- •Hypnagogic Hallucinations
- •Posterior Reversible Encephalopathy Syndrome
- •Neurodegenerative Disease
- •Multiple Sclerosis
- •Schizophrenia
- •Hallucinogenic Drug Use
- •Cannabinoid Use
- •Toxic and Nontoxic Drug Effects
- •Antimetabolites and Cancer Therapy
- •Digitalis
- •Erythropoietin
- •Atropine (Anticholinergic Drugs)
- •Carbon Monoxide
- •Summary of Clinical Approach to the Child with Transient Visual Disturbances
- •Unexplained Visual Loss in Children
- •Transient Amblyogenic Factors
- •Refractive Abnormalities
- •Cornea
- •Retina
- •Optic Nerve
- •Central Nervous System
- •Psychogenic Visual Loss in Children
- •Clinical Profile
- •Neuro-Ophthalmologic Findings
- •Group 1: The Visually Preoccupied Child
- •Group 2: Conversion Disorder
- •Group 3: Possible Factitious Disorder
- •Group 4: Psychogenic Visual Loss Superimposed on True Organic Disease
- •Interview with the Parents
- •Interview with the Child
- •When to Refer Children with Psychogenic Visual Loss for Psychiatric Treatment
- •Horizons
- •References
- •Chapter 6
- •Ocular Motor Nerve Palsies in Children
- •Introduction
- •Oculomotor Nerve Palsy
- •Clinical Anatomy
- •Nucleus
- •Fascicle
- •Clinical Features
- •Isolated Inferior Rectus Muscle Palsy
- •Isolated Inferior Oblique Muscle Palsy
- •Isolated Internal Ophthalmoplegia
- •Isolated Divisional Oculomotor Palsy
- •Oculomotor Synkinesis
- •Etiology
- •Congenital Third Nerve Palsy
- •Congenital Third Nerve Palsy with Cyclic Spasm
- •Traumatic Third Nerve Palsy
- •Meningitis
- •Ophthalmoplegic Migraine
- •Recurrent Isolated Third Nerve Palsy
- •Cryptogenic Third Nerve Palsy in Children
- •Vascular Third Nerve Palsy in Children
- •Postviral Third Nerve Palsy
- •Differential Diagnosis
- •Management
- •Amblyopia
- •Ocular Alignment
- •Ptosis
- •Trochlear Nerve Palsy
- •Clinical Anatomy
- •Clinical Features
- •Head Posture
- •Three-Step Test
- •Bilateral Trochlear Nerve Palsy
- •Etiology
- •Traumatic Trochlear Nerve Palsy
- •Congenital Trochlear Nerve Palsy
- •Large Vertical Fusional Vergence Amplitudes
- •Facial Asymmetry
- •Synostotic Plagiocephaly
- •Hydrocephalus
- •Idiopathic
- •Compressive Lesions
- •Rare Causes of Trochlear Nerve Palsy
- •Differential Diagnosis
- •Treatment
- •Abducens Nerve Palsy
- •Clinical Anatomy
- •Clinical Features
- •Causes of Sixth Nerve Palsy
- •Congenital Sixth Nerve Palsy
- •Traumatic Sixth Nerve Palsy
- •Benign Recurrent Sixth Nerve Palsy
- •Pontine Glioma
- •Elevated Intracranial Pressure
- •Infectious Sixth Nerve Palsy
- •Inflammatory Sixth Nerve Palsy
- •Rare Causes of Sixth Nerve Palsy
- •Differential Diagnosis
- •Duane Retraction Syndrome
- •Genetics
- •Other Clinical Features of Duane Syndrome
- •Upshoots and Downshoots
- •Y or l Pattern
- •Synergistic Divergence
- •Rare Variants
- •Systemic Associations
- •Etiology of Duane Syndrome
- •Classification of Duane Syndrome on the Basis of Range of Movement
- •Embryogenesis
- •Surgical Treatment of Duane Syndrome
- •Esotropia in Duane Syndrome
- •Duane Syndrome with Exotropia
- •Bilateral Duane Syndrome
- •Management of Sixth Nerve Palsy
- •Multiple Cranial Nerve Palsies in Children
- •Horizons
- •References
- •Chapter 7
- •Complex Ocular Motor Disorders in Children
- •Introduction
- •Strabismus in Children with Neurological Dysfunction
- •Visuovestibular Disorders
- •Neurologic Esotropia
- •Spasm of the Near Reflex
- •Exercise-Induced Diplopia
- •Neurologic Exotropia
- •Convergence Insufficiency
- •Skew Deviation
- •Horizontal Gaze Palsy in Children
- •Congenital Ocular Motor Apraxia
- •Vertical Gaze Palsies in Children
- •Downgaze Palsy in Children
- •Upgaze Palsy in Children
- •Diffuse Ophthalmoplegia in Children
- •Myasthenia Gravis
- •Transient Neonatal Myasthenia
- •Congenital Myasthenic Syndromes
- •Juvenile Myasthenia
- •Olivopontocerebellar Atrophy
- •Botulism
- •Bickerstaff Brainstem Encephalitis
- •Tick Paralysis
- •Wernicke Encephalopathy
- •Miscellaneous Causes of Ophthalmoplegia
- •Transient Ocular Motor Disturbances of Infancy
- •Transient Neonatal Strabismus
- •Transient Idiopathic Nystagmus
- •Tonic Downgaze
- •Tonic Upgaze
- •Neonatal Opsoclonus
- •Transient Vertical Strabismus in Infancy
- •Congenital Ptosis
- •Congenital Fibrosis Syndrome
- •Möbius Sequence
- •Monocular Elevation Deficiency, or “Double Elevator Palsy”
- •Brown Syndrome
- •Other Pathologic Synkineses
- •Internuclear Ophthalmoplegia
- •Cyclic, Periodic, or Aperiodic Disorders Affecting Ocular Structures
- •Ocular Neuromyotonia
- •Eye Movement Tics
- •Eyelid Abnormalities in Children
- •Congenital Ptosis
- •Excessive Blinking in Children
- •Hemifacial Spasm
- •Eyelid Retraction
- •Apraxia of Eyelid Opening
- •Pupillary Abnormalities
- •Congenital Bilateral Mydriasis
- •Accommodative Paresis
- •Adie Syndrome
- •Horner Syndrome
- •References
- •Chapter 8
- •Nystagmus in Children
- •Introduction
- •Infantile Nystagmus
- •Clinical Features
- •Onset of Infantile Nystagmus
- •Terminology
- •History and Physical Examination
- •Relevant History
- •Physical Examination
- •Hemispheric Visual Evoked Potentials
- •Immature Infantile Nystagmus Waveforms
- •Mature Infantile Nystagmus Waveforms
- •Fixation in Infantile Nystagmus
- •Smooth Pursuit System in Infantile Nystagmus
- •Vestibulo-ocular Reflex in Infantile Nystagmus
- •Saccadic System in Infantile Nystagmus
- •Suppression of Oscillopsia in Infantile Nystagmus
- •Albinism
- •Achiasmia
- •Isolated Foveal Hypoplasia
- •Congenital Retinal Dystrophies
- •Cone and Cone-Rod Dystrophies
- •Achromatopsia
- •Blue Cone Monochromatism
- •Leber Congenital Amaurosis
- •Alström Syndrome
- •Rod-Cone Dystrophies
- •Congenital Stationary Night Blindness
- •Medical Treatment
- •Optical Treatment
- •Surgical Treatment
- •Surgery to Improve Torticollis
- •Surgery to Improve Vision
- •Tenotomy with Reattachment
- •Four Muscle Recession
- •Artificial Divergence Surgery
- •When to Obtain Neuroimaging Studies in Children with Nystagmus
- •Treatment
- •Spasmus Nutans
- •Russell Diencephalic Syndrome of Infancy
- •Monocular Nystagmus
- •Nystagmus Associated with Infantile Esotropia
- •Torsional Nystagmus
- •Horizontal Nystagmus
- •Latent Nystagmus
- •Treatment of Manifest Latent Nystagmus
- •Nystagmus Blockage Syndrome
- •Treatment of Nystagmus Blockage Syndrome
- •Vertical Nystagmus
- •Upbeating Nystagmus in Infancy
- •Congenital Downbeat Nystagmus
- •Hereditary Vertical Nystagmus
- •Periodic Alternating Nystagmus
- •Seesaw Nystagmus
- •Congenital versus Acquired Seesaw Nystagmus
- •Saccadic Oscillations that Simulate Nystagmus
- •Convergence-Retraction Nystagmus
- •Opsoclonus and Ocular Flutter
- •Causes of Opsoclonus
- •Kinsbourne Encephalitis
- •Miscellaneous Causes
- •Pathophysiology
- •Voluntary Nystagmus
- •Ocular Bobbing
- •Neurological Nystagmus
- •Pelizaeus-Merzbacher Disease
- •Joubert Syndrome
- •Santavuori-Haltia Disease
- •Infantile Neuroaxonal Dystrophy
- •Down Syndrome
- •Hypothyroidism
- •Maple Syrup Urine Disease
- •Nutritional Nystagmus
- •Epileptic Nystagmus
- •Summary
- •References
- •Chapter 9
- •Torticollis and Head Oscillations
- •Introduction
- •Torticollis
- •Ocular Torticollis
- •Head Tilts
- •Incomitant Strabismus
- •Synostotic Plagiocephaly
- •Spasmus Nutans
- •Infantile Nystagmus
- •Benign Paroxysmal Torticollis of Infancy
- •Dissociated Vertical Divergence
- •Ocular Tilt Reaction
- •Photophobia, Epiphora, and Torticollis
- •Down Syndrome
- •Spasmodic Torticollis
- •Head Turns
- •Seizures
- •Cortical Visual Insufficiency
- •Congenital Ocular Motor Apraxia
- •Vertical Head Positions
- •Refractive Causes of Torticollis
- •Neuromuscular Causes of Torticollis
- •Congenital Muscular Torticollis
- •Systemic Causes of Torticollis
- •Head Oscillations
- •Head Nodding with Nystagmus
- •Spasmus Nutans
- •Infantile Nystagmus
- •Head Nodding without Nystagmus
- •Bobble-Headed Doll Syndrome
- •Cerebellar Disease
- •Benign Essential Tremor
- •Paroxysmal Dystonic Head Tremor
- •Autism
- •Infantile Spasms
- •Congenital Ocular Motor Apraxia
- •Opsoclonus/Myoclonus
- •Visual Disorders
- •Blindness
- •Intermittent Esotropia
- •Otological Abnormalities
- •Labyrinthine Fistula
- •Systemic Disorders
- •Aortic Regurgitation
- •Endocrine and Metabolic Disturbances
- •Nasopharyngeal Disorders
- •Organic Acidurias
- •References
- •Chapter 10
- •Introduction
- •Neuronal Disease
- •Neuronal Ceroid Lipofuscinosis
- •Infantile NCL (Santavuori-Haltia Disease)
- •Late Infantile (Jansky–Bielschowsky Disease)
- •Juvenile NCL (Batten Disease)
- •Lysosomal Diseases
- •Gangliosidoses
- •GM2 Type I (Tay–Sachs Disease)
- •GM2 Type II (Sandhoff Disease)
- •GM2 Type III
- •Niemann–Pick Disease
- •Gaucher Disease
- •Mucopolysaccharidoses
- •MPS1H (Hurler Syndrome)
- •MPS1S (Scheie Syndrome)
- •MPS2 (Hunter Syndrome)
- •MPS3 (Sanfilippo Syndrome)
- •MPS4 (Morquio Syndrome)
- •MPS6 (Maroteaux–Lamy Syndrome)
- •MPS7 (Sls Syndrome)
- •Sialidosis
- •Subacute Sclerosing Panencephalitis
- •White Matter Disorders
- •Metachromatic Leukodystrophy
- •Krabbe Disease
- •Pelizaeus–Merzbacher Disease
- •Cockayne Syndrome
- •Alexander Disease
- •Sjögren–Larsson Syndrome
- •Cerebrotendinous Xanthomatosis
- •Peroxisomal Disorders
- •Zellweger Syndrome
- •Adrenoleukodystrophy
- •Basal Ganglia Disease
- •Wilson Disease
- •Maple Syrup Urine Disease
- •Homocystinuria
- •Abetalipoproteinemia
- •Mitochondrial Encephalomyelopathies
- •Myoclonic Epilepsy and Ragged Red Fibers (MERRF)
- •Mitochondrial Depletion Syndrome
- •Congenital Disorders of Glycosylation
- •Horizons
- •References
- •Chapter 11
- •Introduction
- •The Phakomatoses
- •Neurofibromatosis (NF1)
- •Neurofibromatosis 2 (NF2)
- •Tuberous Sclerosis
- •Sturge–Weber Syndrome
- •von Hippel–Lindau Disease
- •Ataxia Telangiectasia
- •Linear Nevus Sebaceous Syndrome
- •Klippel–Trenauney–Weber Syndrome
- •Brain Tumors
- •Suprasellar Tumors
- •Pituitary Adenomas
- •Rathke Cleft Cysts
- •Arachnoid Cysts
- •Cavernous Sinus Lesions
- •Hemispheric Tumors
- •Hemispheric Astrocytomas
- •Gangliogliomas and Ganglioneuromas
- •Supratentorial Ependymomas
- •Primitive Neuroectodermal Tumors
- •Posterior Fossa Tumors
- •Medulloblastoma
- •Cerebellar Astrocytoma
- •Ependymoma
- •Brainstem Tumors
- •Tumors of the Pineal Region
- •Meningiomas
- •Epidermoids and Dermoids
- •Gliomatosis Cerebri
- •Metastasis
- •Hydrocephalus
- •Hydrocephalus due to CSF Overproduction
- •Noncommunicating Hydrocephalus
- •Communicating Hydrocephalus
- •Aqueductal Stenosis
- •Tumors
- •Intracranial Hemorrhage
- •Intracranial Infections
- •Chiari Malformations
- •Chiari I
- •Chiari II
- •Chiari III
- •The Dandy–Walker Malformation
- •Congenital, Genetic, and Sporadic Disorders
- •Clinical Features of Hydrocephalus
- •Ocular Motility Disorders in Hydrocephalus
- •Dorsal Midbrain Syndrome
- •Visual Loss in Hydrocephalus
- •Effects and Complications of Treatment
- •Vascular Lesions
- •AVMs
- •Clinical Features of AVMs in Children
- •Natural History
- •Treatment
- •Cavernous Angiomas
- •Intracranial Aneurysms
- •Isolated Venous Ectasia
- •Craniocervical Arterial Dissection
- •Strokes in Children
- •Cerebral Venous Thrombosis
- •Cerebral Dysgenesis and Intracranial Malformations
- •Destructive Brain Lesions
- •Porencephaly
- •Hydranencephaly
- •Encephalomalacia
- •Colpocephaly
- •Malformations Due to Abnormal Stem Cell Proliferation or Apoptosis
- •Schizencephaly
- •Hemimegalencephaly
- •Lissencephaly
- •Gray Matter Heterotopia
- •Malformations Secondary to Abnormal Cortical Organization and Late Migration
- •Polymicrogyria
- •Holoprosencephaly
- •Absence of the Septum Pellucidum
- •Hypoplasia, Agenesis, or Partial Agenesis of the Corpus Callosum
- •Focal Cortical Dysplasia
- •Anomalies of the Hypothalamic–Pituitary Axis
- •Posterior Pituitary Ectopia
- •Empty Sella Syndrome
- •Encephaloceles
- •Transsphenoidal Encephalocele
- •Orbital Encephalocele
- •Occipital Encephalocele
- •Cerebellar Malformations
- •Molar Tooth Malformation
- •Rhombencephalosynapsis
- •Lhermitte–Duclos Disease
- •Miscellaneous
- •Congenital Corneal Anesthesia
- •Reversible Posterior Leukoencephalopathy
- •Cerebroretinal Vasculopathies
- •Syndromes with Neuro-Ophthalmologic Overlap
- •Proteus Syndrome
- •PHACE Syndrome
- •Encephalocraniocutaneous Lipomatosis
- •References
- •Index
Causes of Optic Atrophy in Children |
177 |
|
|
While there is no known treatment for LHON, experimental rescue of LHON cells with the 11778 mutation using adeno-associated viral vector containing the human mitochondrial superoxide dismutase (SOD2) gene offers promise that gene therapy may soon play a role in the treatment of LHON and other mitochondrial disease.326,697
Recessive Optic Atrophy
Recessively inherited optic atrophies are a heterogeneous group of disorders. One end of the spectrum is represented by complex and overlapping conditions such as Behr’s optic atrophy and Costeff syndrome, as well as various recessively inherited neurologic disorders that show optic atrophy as one of their manifestations. The other end of the spectrum is represented by a monosymptomatic, isolated, rare form of hereditary optic atrophy that occurs as an autosomal recessive disorder.
Simple recessive optic atrophy is present at birth or develops at an early age.268,457,911 The visual deficit in this rare disorder is more pronounced than in dominant optic atrophy, with acuities worse than 2/200 and achromatopsia or severe dyschromatopsia being characteristic. The condition is therefore detected earlier in life than dominant atrophy, usually within the first several years of life, and is usually associated with nystagmus. Occasionally, the condition is noted in the neonatal period and labeled as congenital. Visual fields show variable constriction, often with paracentral scotomas. Because of the rarity of the condition, other, more common, disorders must first be excluded by thorough clinical, electrophysiological, and neuroimaging means.172
The optic discs show profound diffuse atrophy, often with deep cupping. Attenuation of the peripapillary retinal arteriolar vessels has been described, suggesting that at least some such cases might have represented undiagnosed retinal dystrophies such as Leber congenital amaurosis or autosomal recessive cone dystrophy with associated optic atrophy that went unrecognized in the pre-ERG era.267 Therefore, a complete retinal evaluation and a normal ERG are essential to make a diagnosis of autosomal recessive optic atrophy. In an infant with Leber congenital amaurosis, however, optic atrophy is distinctly unusual,745 and a compressive intracranial etiology should be sought. Also, histopathologic studies of eyes with Leber congenital amaurosis have revealed intact optic nerves, the outer nuclear layer and photoreceptors being the primary site of retinal pathology.744
Although some authors have cast doubt on the existence of simple, monosymptomatic, recessively inherited optic atrophy as a distinct entity,583 the locus for autosomal recessive isolated optic atrophy was recently mapped to the long
arm of chromosome 8 in a French family.48 Given the rarity of this disorder, the diagnosis should be one of exclusion that carries with it the need for specific genetic counseling to prospective parents.
X-Linked Optic Atrophy
Several pedigrees with isolated X-linked optic atrophy have been documented.
Assink et al34 analyzed four males from a Dutch pedigree with X-linked optic atrophy who had visual acuities between 20/80 and 20/1,000, with severe optic atrophy and severe color vision defects that differed from dominant optic atrophy by the absence of tritanopia. Katz et al430 found similar linkage in 15 members of an extended pedigree. Affected individuals have visual acuities ranging from 20/30 to 20/100 with significant optic atrophy, absence of nystagmus in most patients, and no other neurologic abnormalities. Obligate female carriers had normal acuity, color vision, perimetry, and normal disc appearances. The gene product for OPA2 has not yet been determined.363
Older reports of X-linked optic atrophy probably included a diversegroupofpatients,someofwhomhadCharcot–Marie–Tooth disease, with others having Rosenberg–Chutorian syndrome.430
Behr Syndrome
In 1909, Behr59 described a variant of recessive optic atrophy that also occurs in early childhood (1–8 years). It differs from the simple variety previously described in that it is associated with other abnormalities, including ataxia, pyramidal and extrapyramidal dysfunction, hypertonia, juvenile spastic paresis, mental retardation, urinary incontinence, and pes cavus. Muscle contractures, mainly of the hip adductors, hamstrings, and soleus, are progressive and become more prominent in the second decade.170 Although usually autosomal recessive, pseudodominant and autosomal dominant inheritance do occur. The visual disability and optic atrophy are severe, showing a variable period of progression that does not usually extend beyond childhood. Sensory nystagmus occurs in over half of the patients. MR neuroimaging in a 6-year-old girl with this syndrome demonstrated diffuse, symmetric white matter abnormalities, including the optic radiations, internal capsule, and centrum semiovale.543
It is doubtful that Behr optic atrophy is a distinct entity, with recent evidence suggesting that the syndrome may represent a number of nosologically and genetically separate disorders. Some cases may represent undiagnosed
178 |
4 Optic Atrophy in Children |
|
|
adrenoleukodystrophy or hereditary ataxia during the era when diagnostic testing for these entities was not available. Other cases may represent undiagnosed cases of 3-methyl- glutaconic aciduria,175,794 a syndrome with similar clinical features to Behr syndrome. Sheffer794 examined three patients who fulfilled the diagnostic criteria of Behr syndrome and who excreted excessive amounts of 3-methylglutaconic acid and 3-methylglutaric acid in their urine. This autosomal recessive disorder, also known as methylglutconic aciduria type III or Costeff syndrome, is characterized by early bilateral optic atrophy, later-onset spasticity, extrapyramidal dysfunction, ataxia, and occasional cognitive defects.174,175,236,363 Patients with Costeff syndrome tend to have extrapyramidal dysfunction without ataxia, whereas those with Behr syndrome tend to have ataxia without extrapyramidal dysfunction, although some overlap exists.175 It is caused by a homozygous mutation in the optic atrophy 3 gene (OPA3), which encodes a protein that is localized to the mitochondrial inner membrane.363 Homozygous mutations with complete absence of the OPA3 gene produce Costeff syndrome, whereas missense mutations in one copy of the OPA3 gene produce autosomal dominant optic atrophy with cataract.363
Straussberg et al829 reported seven Iraqi Jewish children with 3-methyl glutaconic aciduria who were initially misdiagnosed as having cerebral palsy and cautioned that this diagnosis should be considered in the differential diagnosis of cerebral palsy, especially when neurologic symptoms are slowly progressive. Because the two disorders may be clinically indistinguishable, testing for elevated urinary excretion of 3-methylglutaconic acid should be included in the diagnostic evaluation of Behr syndrome.
The diagnosis of Behr syndrome should be considered in patients with heredofamilial ataxia and optic atrophy.253 Its differential diagnosis includes NARP (nyctalopia, ataxia, retinitis pigmentosa) syndrome,292 Marinesco–Sjogren syndrome (a rare autosomal recessive disorder featuring cataracts, cerebellar ataxia, and mental retardation)288 and other spinocerebellar degenerations,181 and other rare congenital cerebellar ataxias such as CAMOS (cerebellar ataxia associated with mental retardation, optic atrophy, and skin abnormalities) syndrome,196 CAPOS (cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss) syndrome,624 and Nyssen–Van Boegaert syndrome.484 Because there are no hallmarks, the diagnosis of Behr’s syndrome is based on exclusion criteria.253
Wolfram Syndrome (DIDMOAD)
Originally described as an association of diabetes mellitus and optic atrophy by Wolfram,937 the spectrum of this syndrome was subsequently expanded to include central diabetes insipidus, diabetes mellitus, optic atrophy, and sensorineural
Table 4.3 Neurologic manifestations of Wolfram (DIDMOAD) syndrome
Diabetes insipidus Optic atrophy Nystagmus Ptosis
Lacrimal hyposecretion
Pupillary abnormalities (e.g., internal ophthalmoplegia) Sensorineural deafness
Seizures
Anosmia Psychiatric disorders Low IQ
Ataxia
Hypogonadotrophic hypogonadism Neurogenic bladder
deafness (hence, the acronym DIDMOAD).22,680,747,757,893 Other, less common, phenotypic features include ptosis, brachydactyly, anosmia, ataxia, nystagmus, seizures, mental retardation, psychiatric disorders, abnormal ERG, elevated protein and cell count in the spinal fluid, small stature, congenital heart disease, myocarditis, and genitourinary abnormalities (Table 4.3).497,708 The typical urinary tract abnormalities include muscular atony with bilateral hydronephrosis and hydro ureters. The mode of inheritance is generally considered autosomal recessive or sporadic, but recently, some cases of Wolfram syndrome have been proposed to represent a mito- chondrial-mediated disorder. It has been suggested that the constellation of findings in Wolfram syndrome fulfill the criteria for a genetic defect of the mitochondrial energy supply.108 These criteria include the following (1) an unexplained association of symptoms and signs, (2) with an early onset and a rapidly progressive course, and (3) which involves seemingly unrelated organs that share no common embryological origin or biological function.598 Alternatively, a combination of mitochondrial and nuclear genetic defects have been postulated to explain the pleiotropic features of DIDMOAD syndrome.108 Some have proposed that the DIDMOAD syndrome results from an inherited abnormality of thiamine metabolism.83
The optic atrophy initially shows rapid progression then plateaus before complete blindness occurs in most cases. Vision is usually reduced to less than 20/200. Pigmentary retinopathy and abnormal ERGs have been described in some cases, indicating the possibility of a more widespread retinal abnormality.
The ages of most patients described in the literature are under 25 years, with many under 15 years. The onsets of the various manifestations of the syndrome are usually temporally separated from each other by months to years. The mean age at diagnosis of diabetes mellitus is 9 years, optic atrophy at 12 years, and diabetes insipidus at 15–20 years. Hearing loss may be detectable only by audiography before the age of 20 years. The fact that diabetes mellitus occurs first in most patients led to the earlier impression that many
Toxic/Nutritional Optic Neuropathy |
179 |
|
|
of the features of the syndrome represent diabetic microvascular complications. This now seems unlikely.453 Optic atrophy and other neurologic abnormalities may appear before diabetes mellitus and usually develop in the absence of any complications related to hyperglycemia.321 The syndrome may remain unrecognized in many patients because the symptoms, except diabetes mellitus and optic atrophy, occur with varying expressivity.159,217 The occurrence of optic atrophy and diabetes mellitus without other manifestations of the syndrome makes the diagnosis difficult to establish, especially in sporadic cases.
The DIDMOAD syndrome should be suspected in diabetic children with unexplained visual loss or persistent polyurea and polydipsia (due to unsuspected diabetes insipidus) in the presence of adequate blood sugar control. The associated hearing loss may be subtle, often a mild highfrequency loss, and must be investigated. Atonia of the efferent urinary tract, which is said to occur in half of patients, is associated with recurrent urinary tract infections and even fatal complications.52 Other systemic and neurologic abnormalities may include regression of milestones, seizures, myoclonus, choreiform movements, ataxia, abnormal behavior, and a bleeding diathesis (Table 4.3).23,137,555 Median age at death is 30 years, most commonly attributable to central respiratory failure with brainstem atrophy.137
MR imaging is highly abnormal, with widespread atrophic changes involving the brainstem, middle cerebellar peduncle, and cerebellum, along with the absence of the high-intensity signal of the posterior pituitary that is consistent with degeneration of the supraoptic and paraventricular nuclei of the hypothalamus.398,660,708,778 In one 12-year-old girl, however, T2-weighted and proton density images showed high signal in the right substantia nigra with no evidence of atrophy.275
Differentiation from simple recessive optic atrophy is made on the basis of the congenital onset and the isolated nature of simple recessive optic atrophy. DIDMOAD is readily distinguished from complicated forms of recessive optic atrophy (such as Behr or Costeff syndrome) on the basis of the serious CNS dysfunction (mental retardation, spasticity, hypertonia, ataxia) and the early age of onset of Behr syndrome. The disorder should be readily differentiated from other disorders showing a combination of diabetes mellitus and optic atrophy, namely Friedreich ataxia, infantile Refsum disease, Alstrom syndrome, and Bardet–Biedl syndrome. The DIDMOAD syndrome can be distinguished from other syndromes showing a combination of optic atrophy and hearing loss, such as Sylvestor syndrome,840 Jensen syndrome,407 or a recently described syndrome showing a triad of optic atrophy, hearing loss, and peripheral neuropathy334 on the basis of other clinical characteristics, the time course of emergence of the various stigmata, and the modes of transmission.
Mutations in the WFS1 gene at 4p16.3 are associated with either optic atrophy as part of the autosomal recessive
Wolfram syndrome, with dominant optic atrophy with hearing loss, or with autosomal dominant progressive low-frequency sensorineural hearing loss without any ophthalmological abnormalities.213,229,739 In several families with presumed autosomal dominant inheritance, Wolfram gene was localized to the short arm of chromosome 4 (4p16.1).684 However, this locus does not account for all Wolfram pedigrees. The gene at this locus has been designated WFS1, and multiple point mutations and deletions have been identified.354,891 Some of these mutations have been found to be a common cause of inherited isolated low-frequency hearing loss. In one report,53 the locus on chromosome 4p16 was proposed as a predisposing factor for the formation of multiple mitochondrial deletions. DIDMOAD patients were also found to exhibit a preponderance of two major mtDNA haplotypes that are also overrepresented among LHON patients.364 That many associated abnormalities in Wolfram syndrome are commonly encountered in patients with mitochondrial disease has led to speculation that the Wolfram phenotype may be nonspecific and reflect a wide array of underlying genetic defects in either the nuclear or mitochondrial genomes, with a unifying pathogenesis in mitochondrial dysfunction.618
Toxic/Nutritional Optic Neuropathy
Symmetrical, usually insidious bilateral optic neuropathy may result from nutritional deficiency (e.g., thiamine, vitamin B12, pyridoxine, folic acid, cobalamin, riboflavin). Children with a history of malnutrition, on starvation diets (e.g., teenagers with anorexia) or other unusually restrictive diets, or gastrointestinal malabsorption disorders should be particularly suspected of harboring this diagnosis (Fig. 4.13). The diagnosis of vitamin B12 deficiency should be considered in the child with “sporadic” dominant optic atrophy (R. Michael Siatkowski, verbal communication). Hoyt and Billson372 described two children who developed symmetrical, bilateral optic neuropathy while being treated with ketogenic diets for seizure control. Both patients recovered normal visual acuity following treatment with thiamine. The epidemic optic neuropathy afflicting Tanzanian schoolchildren in their second decade of life may be partly attributable to low serum levels of B group vitamins.91a
Optic atrophy may arise from adverse metabolic effects of certain drugs (e.g., ethambutol, chloramphenicol, rifampin, Carmistine [BCNU], vincristine) and toxins (e.g., methanol, lead, cobalt). Numerous substances have been implicated in causing optic atrophy.313,355 Chloramphenicol can produce an optic neuropathy that is akin to Leber Hereditary optic neuropathy.789 Before its discontinuation, some patients with cystic fibrosis treated with chloramphenicol presented with sudden bilateral loss of vision, central scotomas, papilledema, engorgement of the retinal veins, and subsequent disc pallor.355 It was subsequently discovered that chloramphenicol acts as
